Drug-eluting bead transarterial chemoembolization could improve the hepatic hemodynamics of patients with unresectable hepatocellular carcinoma: a retrospective cohort study.
Journal of gastrointestinal oncology(2023)
摘要
DEB-TACE can improve hepatic hemodynamics in HCC patients, especially those with CSPH. Combing these findings with its effects on tumor, DEB-TACE might be more suitable for HCC patients with cirrhosis.
更多查看译文
关键词
Clinically significant portal hypertension (CSPH),drug-eluting bead transarterial chemoembolization (DEB-TACE),hepatic hemodynamics,hepatic venous pressure gradient (HVPG),hepatocellular carcinoma (HCC)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要